Life
U.S. Venture Capital Firms Shift Focus to Upstream Biotech Investments in China
Amid intensifying competition, U.S. venture capital firms are adapting their strategies by investing directly in upstream scientific pipelines within China's biotech sector.
Editorial Staff 6 days ago